Skip to main content

Advertisement

Log in

Disseminated BCG Disease in a Patient with Hyper IgE Syndrome due to Dominant-Negative STAT3 Mutation—Case Report

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Data Availability

All data generated or analyzed during this study are included in this published article (and its supplementary information files).

References

  1. Asano T, Khourieh J, Zhang P, et al. Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance. J Exp Med. 2021;218(8): e20202592. https://doi.org/10.1084/jem.20202592.

    Article  CAS  Google Scholar 

  2. Tsilifis C, Freeman AF, Gennery AR. STAT3 hyper-IgE syndrome-an update and unanswered questions. J Clin Immunol. 2021;41(5):864–80. https://doi.org/10.1007/s10875-021-01051-1.

    Article  CAS  Google Scholar 

  3. Mahdaviani SA, Fallahi M, Jamee M, et al. Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian susceptibility to mycobacterial disease (MSMD): a case series. Ann Clin Microbiol Antimicrob. 2022;21:8. https://doi.org/10.1186/s12941-022-00500-y.

    Article  CAS  Google Scholar 

  4. Martínez-Barricarte R, Markle JG, Ma CS, et al. Human IFN-γ immunity to mycobacteria is governed by both IL-12 and IL-23. Sci Immunol. 2018;3(30):eaau6759. https://doi.org/10.1126/sciimmunol.aau6759.

    Article  Google Scholar 

  5. Staels F, Lorenzetti F, De Keukeleere K, et al. A novel homozygous stop mutation in IL23R causes Mendelian susceptibility to mycobacterial disease [published online ahead of print, 2022 Jul 13]. J Clin Immunol. 2022. https://doi.org/10.1007/s10875-022-01320-7

  6. Boisson-Dupuis S, Ramirez-Alejo N, Li Z, et al. Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common TYK2 missense variant. Sci Immunol. 2018;3(30):eaau8714. https://doi.org/10.1126/sciimmunol.aau8714.

    Article  Google Scholar 

Download references

Acknowledgements

Consortium information

2Epidemiology and Infectious Diseases Department, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina

3Dermatology Department, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina

4Pathology Department, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina

5Microbiology Department, Hospital Nacional de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina

Author information

Authors and Affiliations

Authors

Consortia

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Luciano Urdinez, Goris Veronica; Silvia Danielian, Matias Oleastro, and all consortium members. The first draft of the manuscript was written by Luciano Urdinez and all authors commented on previous versions of the manuscript. All authors and consortium members read and approved the final manuscript.

Corresponding author

Correspondence to Luciano Urdinez.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

Patients or legal guardians have given written consent for publication.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 470 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Urdinez, L., Goris, V., Danielian, S. et al. Disseminated BCG Disease in a Patient with Hyper IgE Syndrome due to Dominant-Negative STAT3 Mutation—Case Report. J Clin Immunol 43, 65–68 (2023). https://doi.org/10.1007/s10875-022-01359-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-022-01359-6

Navigation